A Mycobacterium tuberculosis-Infected Patient Who Could Not Tolerate Oral Intake Successfully Treated Using an Intravenous Tedizolid-Containing Regimen

Haruka Karaushi; Masafumi Seki; Yutaka Miyawaki; Noriyuki Watanabe; Fumitaka Kamoshita; Kotaro Mitsutake

doi:10.12659/AJCR.937485

10 October 2022 : Case report Japan

A Mycobacterium tuberculosis-Infected Patient Who Could Not Tolerate Oral Intake Successfully Treated Using an Intravenous Tedizolid-Containing Regimen

Unusual or unexpected effect of treatment

Haruka Karaushi^12ABCD, Masafumi Seki^1ABCDEFG*, Yutaka Miyawaki

^13ABCD, Noriyuki Watanabe^14BCDF, Fumitaka Kamoshita^1BD, Kotaro Mitsutake^1DEFG

DOI: 10.12659/AJCR.937485

Am J Case Rep 2022; 23:e937485

Authors information Article notes Copyright and License information

Background Case Report Discussion Conclusions References:

Related articles Order reprints Share article Share by email

View HTML version

Figure 3. Improved chest X-ray of the patient. Infiltration shadows of the lower lung fields and cavity formation of the upper lung are diminished and have disappeared (arrows).

Back to the Article

A Mycobacterium tuberculosis-Infected Patient Who Could Not Tolerate Oral Intake Successfully Treated Using an Intravenous Tedizolid-Containing Regimen

Your Privacy